ReportWire

Tag: Generic/Biosimilar Drugs

  • Israeli stocks slump in first day of trade since Gaza attack

    Israeli stocks slump in first day of trade since Gaza attack

    [ad_1]

    Israeli stocks skidded Sunday, reeling one day after the surprise attack from Gaza.

    The benchmark TA-35 index
    IL:TA35
    fell 7% to 1,703.38 in Sunday morning trade, with every constituent except generic drugmaker Teva Pharmaceutical
    TEVA,
    -7.82%
    lower.

    Several companies saw double-digit losses including Newmed Energy
    NWMD,
    -0.44%    ,
    an oil and gas explorer; Delek Group
    DLEKG,
    -4.04%    ,
    which owns the country’s largest chain of gas stations; and Shikun & Binui
    SKBN,
    -0.10%    ,
    an infrastructure company.

    Israeli soldiers were still battling Hamas fights in the streets of southern Israel on Sunday and has launched retaliation strikes on Gaza.

    Israeli media, citing rescue service officials, said at least 300 people were killed, including 26 soldiers, while in Gaza officials said 313 people had died. An Israeli military official said hundreds of militants had been killed and dozens captured.

    — The Associated Press contributed to this report

    [ad_2]

    Source link

  • FDA pulls preterm-birth drug Makena and its generics from market after 12 years

    FDA pulls preterm-birth drug Makena and its generics from market after 12 years

    [ad_1]

    The U.S. Food and Drug Administration said Thursday it had reached a final decision to fully withdraw approval of preterm-birth drug Makena and its generics, a full 12 years after the treatment hit the market.

    The drug was approved in 2011 using the agency’s accelerated-approval pathway as a treatment to reduce the risk of spontaneous preterm birth in pregnant women who had a history of the condition.

    The…

    [ad_2]

    Source link